ANAVEX LIFE SCIENCES CORP. Unamortized Loss Reacquired Debt, Noncurrent
ANAVEX LIFE SCIENCES CORP. (AVXL) had Unamortized Loss Reacquired Debt, Noncurrent of $16.36 thousand as of 2021-09-30, per its 10-K filed 2021-11-24.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedLossReacquiredDebtNoncurrent · last filed 2021-11-24
- 2021-09-30: Unamortized Loss Reacquired Debt, Noncurrent $16.36K.
- 2020-09-30: Unamortized Loss Reacquired Debt, Noncurrent $0.00.
| Period end | Unamortized Loss Reacquired Debt, Noncurrent |
|---|---|
| 2021-09-30 | $16.36K 10-K · filed 2021-11-24 |
| 2020-09-30 | $0.00 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |